Urinary Tract and Identification
Urinary Tract Bacteriology and Identification Methods
On this page
The bladder and upper urinary tract are sterile in health, but the urethra is not. Any non-invasively collected specimen therefore carries some contaminating flora, and interpretation depends on quantitative culture. Urine specimen handling and urinalysis correlation belong with urinalysis; this module owns the loop count, the CFU/mL calculation, and identification of the organisms that grow.1,2
Specimen collection
| Method | Indication | Technique notes |
|---|---|---|
| Midstream clean-catch | Routine, ambulatory patients | Periurethral cleaning (women); initial urine stream discarded to flush urethral flora before the midstream portion is captured |
| Catheterization | Patient unable to produce a clean-catch specimen | First few milliliters discarded to clear catheter-tip contamination; carries nosocomial-infection risk, so use should be restricted to genuine need |
| Indwelling-catheter aspiration | Catheterized patients requiring culture | Aspirate through the disinfected catheter port with a needle and syringe; never sample from the collection bag |
| Suprapubic aspiration | Neonates, or when urethral contamination must be entirely excluded | Needle puncture above the symphysis pubis into a full bladder; bypasses urethral flora entirely, so any growth is potentially significant |
| Nephrostomy tube | Patients with a percutaneous nephrostomy for urinary diversion | Aspirate from the disinfected tube port or collect from fresh drainage. The tract is chronically colonized, so no colony-count threshold reliably separates colonization from infection; interpret results together with the clinical picture. The same caveat applies to chronic indwelling (long-term) catheters and ileal conduits, both colonized by definition |
Specimens should reach the laboratory and be processed within 2 hours, or be refrigerated up to 24 hours if a delay is unavoidable; boric-acid-based preservative transport devices are an alternative when refrigeration cannot be guaranteed. IDSA/ASM 2024 tightens the room-temperature window to about 30 minutes before refrigeration or preservative. Twenty-four-hour urine collections are inappropriate for routine culture and are reserved for specific parasitologic indications (Schistosoma haematobium).2
Quantitative culture and colony-count interpretation
Quantitative culture uses a calibrated loop (0.001 mL for most specimens; 0.01 mL for suspected acute urethral syndrome in women and for suprapubic aspirates) streaked onto agar so that colony counts translate directly into colony-forming units per milliliter:
CFU/mL = colonies counted × (1 ÷ loop volume in mL)
- 0.001 mL loop → multiply colony count by 1,000
- 0.01 mL loop → multiply colony count by 100
Application 1. A 27-year-old woman with dysuria provides a midstream clean-catch urine. Using a 0.001-mL calibrated loop, the plate grows 156 colonies of one predominant lactose-fermenting gram-negative rod. CFU/mL = 156 × 1,000 = 156,000 CFU/mL (1.56 × 105 CFU/mL). The count exceeds the classic ≥105 CFU/mL benchmark for a predominant organism in a voided specimen and is compatible with UTI in the clinical setting; symptomatic-patient algorithms may also recognize lower counts as significant.
Application 2. A neonatal suprapubic aspirate is inoculated with a 0.01-mL loop and yields 11 colonies of a single organism. CFU/mL = 11 × 100 = 1,100 CFU/mL (1.1 × 103 CFU/mL). Because a suprapubic aspirate bypasses the urethral contamination expected with voided urine, even this low colony count is clinically meaningful when a single organism is recovered.
Growth of a single predominant organism at ≥105 CFU/mL from a voided specimen is classically significant; asymptomatic bacteriuria (bacteriuria without symptoms, with or without pyuria) is generally not screened for outside pregnancy and pre-urologic-procedure settings. Mixed growth of multiple organism types at lower counts more often reflects contamination than infection. Many laboratories now also work up 104 or 103 CFU/mL thresholds based on collection method and patient population. The screening tests below help determine which specimens need culture.
Screening methods
Dipstick chemistry combines nitrite (a byproduct of bacterial nitrate reductase, an enzyme most gram-negative uropathogens express) and leukocyte esterase (a neutrophil enzyme marking pyuria). A negative result on both markers argues against UTI, particularly in symptomatic patients, but neither marker alone is sufficiently sensitive to exclude infection. Gram stain of uncentrifuged urine is economical but too labor-intensive for routine high-volume screening; the presence of ≥1 organism per oil-immersion field correlates well with ≥105 CFU/mL. Automated instrument screening (flow cytometry or particle-counting platforms) rapidly excludes specimens unlikely to grow a clinically significant count, improving turnaround for specimens that do require culture.
Urine is an acceptable NAAT specimen for N. gonorrhoeae/C. trachomatis; molecular testing is preferred for BK virus and is commonly used for CMV, adenovirus, and HSV detection in urine. Leptospira interrogans is detectable in urine from the second week of illness onward using specialized enriched semisolid media, but the specimen degrades quickly in the acidic environment of urine and must be processed promptly.
Identification of common urinary pathogens
| Organism | Colony morphology and key reactions in urine culture | Confirmatory test(s) | Clinical context |
|---|---|---|---|
| Staphylococcus saprophyticus | White to yellow colonies on blood agar, often slightly larger than other coagulase-negative staphylococci | Coagulase-negative; novobiocin-resistant on a 5-µg disk, the defining test separating it from other CoNS | Second most common cause of uncomplicated cystitis after E. coli, chiefly in young, sexually active women |
| Enterococcus spp. | Small, gray, nonhemolytic or alpha-hemolytic colonies | PYR-positive, bile-esculin-positive, growth in 6.5% NaCl broth | Catheter-associated and complicated UTI; intrinsic low-level resistance to many agents |
| Streptococcus agalactiae (group B) | Narrow-zone beta-hemolytic colonies | Hippurate hydrolysis-positive, CAMP-positive | Bacteriuria at any colony count during pregnancy is significant, regardless of the antepartum screening-culture result |
| Enterobacterales (E. coli, Klebsiella, Proteus, and others) | Lactose-fermenting, pink colonies on MacConkey (E. coli, Klebsiella); Proteus swarms and is lactose-negative | Full biochemical differentiation as in enteric bacteriology | E. coli causes the large majority of community-acquired UTI; Klebsiella and Proteus follow |
| Candida spp. | White to cream, smooth, yeast-odored colonies on blood or urine-culture agar | Germ tube test (positive for C. albicans) or chromogenic agar for species-level identification | Candiduria is frequently catheter-associated and often represents colonization |
Novobiocin resistance is an identification reaction, not a CLSI M100 clinical breakpoint. Exact millimeter cutoffs for the 5-µg disk are manufacturer- and method-dependent and are not quoted from the paywalled M100-Ed36 tables. Report the isolate as novobiocin-resistant S. saprophyticus when the laboratory’s validated identification method supports that call.3
Phenotypic and biochemical identification
Identification begins with Gram-stain morphology and colony appearance, including pigmentation, hemolysis, odor, swarming, and mucoidy. Spot tests are then selected for the organism group. These include oxidase, catalase, indole, urease, and hippurate hydrolysis. An oxidase-negative result supports Enterobacterales except Plesiomonas, the order’s only oxidase-positive member. Oxidase-positive gram-negative rods include Vibrio, Aeromonas, Campylobacter, Pasteurella, and Capnocytophaga. Conventional biochemical panels such as triple sugar iron, motility-indole-urease, Simmons citrate, and decarboxylase broths remain the reference method for definitive identification when automated or molecular methods are unavailable or discordant. Commercial manual or semi-automated systems use miniaturized panels of dried or lyophilized substrates read after overnight incubation. They are routinely used for bench identification, with good accuracy for common Enterobacterales and higher throughput than fully manual biochemicals.
Coagulase. Coagulase is the classic test separating Staphylococcus aureus from coagulase-negative staphylococci. The slide (rapid) test detects bound coagulase (clumping factor), which binds fibrinogen directly and causes visible clumping within 10 seconds when a colony is emulsified in plasma on a slide; it is fast but misses free coagulase, giving occasional false negatives. The tube test detects free coagulase, which activates a plasma coenzyme that converts fibrinogen to fibrin: a colony suspension in plasma is incubated at 35 °C and examined for any degree of clot formation at 4 hours, with a negative 4-hour result reincubated and re-read at 24 hours because some strains clot slowly. A slide-negative isolate suspected of being S. aureus (typical colony morphology, beta-hemolysis) always requires tube-test confirmation, since essentially all S. aureus are eventually tube-positive but only about 80-90% are slide-positive.
PYR (L-pyrrolidonyl-β-naphthylamide hydrolysis). The organism is inoculated onto a PYR-impregnated disk or in broth; if the enzyme pyrrolidonyl arylamidase is present, it hydrolyzes the substrate to β-naphthylamide, which develops a red color within 1-2 minutes of adding a cinnamaldehyde reagent. Enterococcus spp. and Streptococcus pyogenes (group A Streptococcus) are PYR-positive. Other beta-hemolytic streptococci, including group B, and viridans-group streptococci are PYR-negative. Leuconostoc and Pediococcus are lactic-acid bacteria, also PYR-negative, and are not streptococci. PYR is therefore used to separate group A streptococci from other beta-hemolytic streptococci at the bench, and to separate enterococci from group D streptococci (S. gallolyticus and relatives), which the older bile-esculin/6.5% NaCl panel alone cannot always distinguish reliably.
X and V factor requirements. Haemophilus spp. require hemin (X factor, a heat-stable porphyrin precursor) and/or NAD (V factor, a heat-labile coenzyme) for growth, and the requirement pattern identifies the species. X- and V-factor-impregnated paper strips or a quadrant plate streaked with X, V, and X+V disks are placed on unsupplemented (non-chocolate) medium. Growth only around the combined X+V disk identifies H. influenzae, which requires both factors. Growth around V alone identifies H. parainfluenzae, and H. ducreyi requires X factor only. The porphyrin test is an alternative to the X strip. It detects enzymatic conversion of delta-aminolevulinic acid to porphyrins/porphobilinogen, a pathway found only in organisms that can synthesize their own heme and therefore do not require exogenous X factor. A positive porphyrin test indicates that the organism does not need X factor. The satellite phenomenon provides a simpler bench clue. Sheep blood agar does not supply free V factor because NAD is bound and inactivated by an enzyme in sheep erythrocytes. On this medium, X/V-dependent Haemophilus grows only as tiny colonies clustered around a streak of Staphylococcus aureus, whose hemolysis releases NAD locally.
Neisseria and Moraxella carbohydrate utilization. Cystine trypticase agar (CTA) sugars differentiate oxidase-positive, gram-negative diplococci by acid production. Glucose, maltose, lactose, and sucrose are each tested in a separate tube with a pH indicator. N. gonorrhoeae acidifies glucose only; N. meningitidis acidifies glucose and maltose; N. lactamica acidifies glucose, maltose, and lactose; and Moraxella catarrhalis acidifies none of the four. Positive DNase and butyrate esterase (indoxyl butyrate) spot tests confirm M. catarrhalis and distinguish it from CTA-negative Neisseria species that lack these enzymes.
Mass spectrometry (MALDI-TOF)
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identifies organisms from abundant ribosomal proteins rather than metabolic reactions. A colony, or a formic-acid extract for gram-positive organisms and fungi, is mixed with an acidic matrix compound (sinapinic acid or α-cyano-4-hydroxycinnamic acid). The matrix is dissolved in an ethanol/methanol-acid solvent that penetrates the cell wall and extracts intracellular protein. Laser ionization produces a peptide mass fingerprint of roughly 2-20 kDa, which is matched against a reference database. MALDI-TOF is fast, inexpensive per test after capital investment, and reliably identifies most Enterobacterales, nonfermenters, staphylococci, and anaerobes. It cannot reliably distinguish Shigella spp. from E. coli because of their close genomic and proteomic relationship.
Molecular detection: target selection and amplification
Conserved sequences shared broadly across taxa are poor species-specific targets because they can cross-react, but they are ideal for broad-range detection. Universal bacterial detection by 16S rRNA gene sequencing uses conserved regions to anchor primer binding and hypervariable regions to provide genus/species discrimination. Sequence-unique regions are used for species- or serotype-specific detection. Most routine testing uses FDA-cleared commercial platforms with prevalidated primers and probes. Laboratory-developed tests (“home-brew” assays) fill gaps where no cleared assay exists but require local validation.
Amplification and detection formats relevant to bacteriology include real-time (quantitative) PCR, transcription-mediated amplification, loop-mediated isothermal amplification, and strand-displacement amplification. Real-time PCR is the dominant format because it is closed-tube and quantitative. The closed-tube format minimizes amplicon carryover contamination, and quantitation distinguishes low-level/subclinical detection from high-burden infection. Post-amplification melt-curve analysis measures the temperature at which a double-stranded amplicon dissociates, detected as a drop in fluorescence. This method allows closed-tube genotyping without opening the reaction and is useful for distinguishing closely related targets that share an amplification target region.
Molecular epidemiology and strain typing
Reference laboratories perform molecular strain typing when isolates from different patients, specimens, or times must be compared for outbreak investigation.
References
- Tille PM. Bailey & Scott's Diagnostic Microbiology. 15th ed. Elsevier; 2021.
- Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. Published online March 5, 2024. doi:10.1093/cid/ciae104
- CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 36th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2026. See also the July 9, 2026 correction notice for Table 2H-1.